GRHL3 Gene Van Der Woude Syndrome Type 2 NGS Genetic DNA Test
Introduction
The GRHL3 Gene Van Der Woude Syndrome Type 2 NGS Genetic DNA Test is an advanced diagnostic tool designed to identify mutations in the GRHL3 gene, which are associated with Van Der Woude Syndrome. This syndrome is characterized by cleft lip and/or palate and can also involve other developmental anomalies. Early detection through this test is vital for effective management and treatment planning.
What the Test Measures
This genetic test utilizes Next Generation Sequencing (NGS) technology to analyze the GRHL3 gene. It detects specific mutations that may lead to Van Der Woude Syndrome, allowing for a comprehensive understanding of an individual’s genetic makeup.
Who Should Consider This Test
Individuals who may benefit from this test include:
- Patients with a family history of Van Der Woude Syndrome.
- Individuals presenting with symptoms such as cleft lip or palate.
- Parents seeking genetic counseling for planning future pregnancies.
Benefits of Taking the Test
Taking the GRHL3 Gene Van Der Woude Syndrome Type 2 NGS Genetic DNA Test offers numerous benefits:
- Early diagnosis of genetic conditions.
- Informed decision-making regarding treatment options.
- Genetic counseling for affected family members.
- Peace of mind for prospective parents.
Understanding Your Results
Once the test is completed, results will be provided within 3 to 4 weeks. A qualified genetic counselor will help interpret the findings, explaining the implications of any detected mutations and guiding you through the next steps.
Test Pricing
| Price Type | Amount (NGN) |
|---|---|
| Discount Price | 400,000 NGN |
| Regular Price | 560,000 NGN |
Booking the Test
To book the GRHL3 Gene Van Der Woude Syndrome Type 2 NGS Genetic DNA Test, please contact us at +2348077798758 via call or WhatsApp. Our team is ready to assist you with scheduling and any inquiries you may have.
Pre-Test Instructions
It is essential to provide a detailed clinical history prior to the test. A genetic counseling session is recommended to create a pedigree chart of family members affected by the GRHL3 gene mutation.
